ECCO 15 - ESMO 34 News 20-21 September, 2009
Prof Gordon McVie - ecancer Managing Editor
ECCO 15 - ESMO 34 News 20-21 September, 2009 ( Prof Gordon McVie - ecancer Managing Editor )
21 Sep 2009
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?
Why attend ECCO 15 - ESMO 34?
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin? ( Why attend ECCO 15 - ESMO 34? )
22 Jul 2009
The Oncopolicy Roundtable: ECCO's President and special guests highlight key iss...
ECCO 15 - ESMO 34
The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues ( ECCO 15 - ESMO 34 )
22 Jul 2009
Oncofertility and quality of life
Dr Fedro Peccatori - European Institute of Oncology, Milan, Italy
Oncofertility and quality of life ( Dr Fedro Peccatori - European Institute of Oncology, Milan, Italy )
15 Jul 2009
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston - Queen's University Belfast, UK
Targeting death receptors in chemo-resistant cancer cells ( Prof Patrick Johnston - Queen's University Belfast, UK )
3 Jul 2009
Treatment based on rising CA125 blood levels does not improve survival for recur...
Dr Gordon Rustin - Mount Vernon Cancer Center, UK
Treatment based on rising CA125 blood levels does not improve survival for recurrent ovarian cancer ( Dr Gordon Rustin - Mount Vernon Cancer Center, UK )
3 Jul 2009
Sentinel node biopsy is effective, less invasive option for early-stage cervical...
Dr Fabrice Lecuru - George Pompidou European Hospital, France
Sentinel node biopsy is effective, less invasive option for early-stage cervical cancer patients ( Dr Fabrice Lecuru - George Pompidou European Hospital, France )
3 Jul 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009
AACR 2009: Ovarian cancer biomarkers
Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women's Hospi...
AACR 2009: Ovarian cancer biomarkers ( Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women's Hospital, Harvard Medical School, USA )
1 May 2009
AACR 2009: Genetic variants in microRNA processing pathway genes and ovarian can...
Professor Xifeng Wu - Department of Epidemiology, University of Texas M.D. Ander...
AACR 2009: Genetic variants in microRNA processing pathway genes and ovarian cancer risk ( Professor Xifeng Wu - Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, USA )
30 Apr 2009
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of ...
Bacteria as agents to initiate potent anti-tumour activity ( Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan )
31 Mar 2009